<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tomita H</submitter><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>Smith-Lemli-Opitz/RSH Foundation</funding><pagination>e67141</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9519149</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11</volume><pubmed_abstract>Defective 3β-hydroxysterol-Δ&lt;sup>7&lt;/sup> -reductase (DHCR7) in the developmental disorder, Smith-Lemli-Opitz syndrome (SLOS), results in a deficiency in cholesterol and accumulation of its precursor, 7-dehydrocholesterol (7-DHC). Here, we show that loss of &lt;i>DHCR7&lt;/i> causes accumulation of 7-DHC-derived oxysterol metabolites, premature neurogenesis from murine or human cortical neural precursors, and depletion of the cortical precursor pool, both in vitro and in vivo. We found that a major oxysterol, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), mediates these effects by initiating crosstalk between glucocorticoid receptor (GR) and neurotrophin receptor kinase TrkB. Either loss of &lt;i>DHCR7&lt;/i> or direct exposure to DHCEO causes hyperactivation of GR and TrkB and their downstream MEK-ERK-C/E</pubmed_abstract><journal>eLife</journal><pubmed_title>7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.</pubmed_title><pmcid>PMC9519149</pmcid><funding_grant_id>T32 GM007750</funding_grant_id><funding_grant_id>P30 ES007033</funding_grant_id><funding_grant_id>R01 HD092659</funding_grant_id><funding_grant_id>Research grant</funding_grant_id><funding_grant_id>TL1 TR002318</funding_grant_id><funding_grant_id>T32 ES007032</funding_grant_id><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Herron JM</pubmed_authors><pubmed_authors>Baggett DW</pubmed_authors><pubmed_authors>Tomita H</pubmed_authors><pubmed_authors>Li A</pubmed_authors><pubmed_authors>Hines KM</pubmed_authors></additional><is_claimable>false</is_claimable><name>7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.</name><description>Defective 3β-hydroxysterol-Δ&lt;sup>7&lt;/sup> -reductase (DHCR7) in the developmental disorder, Smith-Lemli-Opitz syndrome (SLOS), results in a deficiency in cholesterol and accumulation of its precursor, 7-dehydrocholesterol (7-DHC). Here, we show that loss of &lt;i>DHCR7&lt;/i> causes accumulation of 7-DHC-derived oxysterol metabolites, premature neurogenesis from murine or human cortical neural precursors, and depletion of the cortical precursor pool, both in vitro and in vivo. We found that a major oxysterol, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), mediates these effects by initiating crosstalk between glucocorticoid receptor (GR) and neurotrophin receptor kinase TrkB. Either loss of &lt;i>DHCR7&lt;/i> or direct exposure to DHCEO causes hyperactivation of GR and TrkB and their downstream MEK-ERK-C/E</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T00:34:53.757Z</modification><creation>2025-04-19T05:16:00.334Z</creation></dates><accession>S-EPMC9519149</accession><cross_references><pubmed>36111785</pubmed><doi>10.7554/eLife.67141</doi></cross_references></HashMap>